Company Search:
Advanced Search
Sponsored Links
iNtRON Biotechnology Inc Company Snapshot
iNtRON Biotechnology Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares iNtRON Biotechnology Inc with three other companies in this sector in South Korea: Bioneer Corporation (2018 sales of 24.08 billion Korean Won [US$21.07 million] of which 100% was Biotechnology business), Legochem Biosciences Inc (25.24 billion Korean Won [US$22.09 million] ), and NanoenTek Incorporated (25.80 billion Korean Won [US$22.57 million] of which 54% was Diagnosis).

Sales Analysis. iNtRON Biotechnology Inc reported sales of 20.58 billion Korean Won (US$18.01 million) for the year ending December of 2018. This represents an increase of 87.8% versus 2017, when the company's sales were 10.96 billion Korean Won.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
iNtRON Biotechnology Inc
  Stock Performance Chart for iNtRON Biotechnology Inc
  Stock Data: Recent Stock Performance:
  Current Price (4/19/2019): 19,100
(Figures in Korean Won)
1 Week -5.0%   13 Weeks -8.4%  
4 Weeks 0.5%   52 Weeks -17.0%  
iNtRON Biotechnology Inc Key Data:
  Ticker: 048530 Country: Korea (South)
  Exchanges: SEO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 20,584,390,702
(Year Ending Jan 2019).
Employees: 101
  Currency: Korean Won Market Cap: 571,941,210,600
  Fiscal Yr Ends: December Shares Outstanding: 29,944,566
  Share Type: Ordinary Closely Held Shares: 6,508,234
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.